Opioids for the treatment of the chronic obstructive pulmonary disease (copd)
AssigneeEuro-Celtique S.A.
InventorsWolfgang Fleischer, Karen Reimer, Petra Leyendecker
Life of this patent
Estimating the term…
Abstract
The present invention relates to an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD).
Claims22
Use of an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD).
Use of an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD) which provides an effective treatment when administered every twelve hours at steady state.
Use of an opioid controlled release oral dosage form comprising at least one opioid for the manufacture of a medicament to treat patients with Chronic Obstructive Pulmonary Disease (COPD) which provides an effective treatment when administered every 24 hours at steady state.
Dependencies are inferred from the claim text.